Influence of graft material on blood theology and plasma biochemistry following insertion of an infrainguinal bypass graft

British Journal of Surgery

Volumn 85, Issue 3, 1998, Pages 351-354

  Woodburn, K R ^a,b   Rumley, A ^a   Love, J G ^a   Murray, G D ^a   Lowe, G D O ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; AUTOGRAFT; BLOOD CHEMISTRY; BLOOD RHEOLOGY; BLOOD VESSEL GRAFT; CLINICAL TRIAL; DACRON IMPLANT; ENDOPROSTHESIS; FEMALE; FIBRINOGEN BLOOD LEVEL; GRAFT INFECTION; GRAFT OCCLUSION; GRAFT PATENCY; HEMATOCRIT; HUMAN; INGUINAL REGION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; SMOKING; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS; VEIN GRAFT;

AGED; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VISCOSITY; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; VASCULAR PATENCY;

EID: 0031885470     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00613.x     Document Type: Article

References (20)

1. Hamer JD, Ashton F, Meynell MJ. Factors influencing prognosis in the surgery of peripheral vascular disease: platelet adhesiveness, plasma fibrinogen, and fibrinolysis. Br J Surg 1973; 60: 386-9.
2. Harris PL, Harvey DR, Bliss BP. The importance of plasma lipid, glucose, insulin and fibrinogen in femoropopliteal surgery. Br J Surg 1978; 65: 197-200.
3. Wiseman S, Kenchington G, Dain R, Marshall CE, McCollum C, Greenhalgh RM et al. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ 1989; 299: 643-6.
4. Woodburn KR, Rumley A, Lowe GDO, Love JG, Murray GD, Pollock JG. Clinical, biochemical, and rheological factors affecting the outcome of infrainguinal bypass grafting. J Vasc Surg 1996; 24: 639-46.
5. Woodburn KR, Rumley A, Lowe GDO, Pollock JG. Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia. Eur J Vasc Endovasc Surg 1995; 10: 272-8.
6. Woodburn KR, Rumley A, Lowe GDO, Pollock JG. Persisting elevation in white cell count and von Willebrand Factor is associated with the development of vein graft stenoses. Br J Surg 1994; 81: A617.
7. Hicks RCJ, Ellis M, Mir-Hasseine R, Higman DJ, Nott D, Greenhalgh RM et al. The influence of fibrinogen concentration on the development of vein graft stenoses. Eur J Vasc Endovasc Surg 1995; 9: 415-20.
8. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87: 1915-20.
9. Woodburn KR, Lowe GDO, Rumley A, Love J, Pollock JG. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1995; 14: 346-52.
10. Woodburn KR, Murtagh A, Breslin P, Reid AW, Pollock JG, Leiberman DP et al. Insonation and impedance analysis in graft surveillance. Br J Surg 1995; 82: 1222-5.
11. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-5.
12. Moody P, de Cossart LM, Douglas HM, Harris PL. Asymptomatic strictures in femoro-popliteal vein grafts. Eur J Vasc Surg 1989; 3: 389-92.
13. Moody P, Gould DA, Harris PL. Vein graft surveillance improves patency in femoro-popliteal bypass. Eur J Vasc Surg 1990; 4: 117-21.
14. De Bakey ME, Jordan GL Jr, Abbott JP, Halpert B, O'Neal RM. The fate of Dacron vascular grafts. Arch Surg 1964; 89: 757-82.
15. Walton KW, Slaney G, Ashton F. Atherosclerosis in vascular grafts for peripheral vascular disease. Part 2. Synthetic arterial prostheses. Atherosclerosis 1986; 61: 155-67.
16. Reid DB. The clinical role of fibrinogen and fibrin in peripheral arterial disease. MD Thesis. University of Glasgow, Glasgow, 1991.
17. Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342: 84-6.
18. Thompson WD, Smith EB, Stirk CM, Kochhar A. Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products. Blood Coagul Fibrinolysis 1990; 1: 489-93.
19. Ritchie DG, Levy BA, Adams MA, Fuller GM. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc Natl Acad Sci U S A 1982; 79: 1530-4.
20. Lorenzet R, Sobel JH, Bini A, Witte LD. Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells. Thromb Haemost 1992; 68: 357-63.